Cargando…
Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections
[Image: see text] Infections with Clostridioides difficile (formerly Clostridium difficile) have increased in incidence, morbidity, and mortality over the past decade. Preventing infections is becoming increasingly important, as frontline antibiotics become less effective and frequently induce recur...
Autores principales: | Broecker, Felix, Wegner, Erik, Seco, Bruna M. S., Kaplonek, Paulina, Bräutigam, Maria, Ensser, Armin, Pfister, Frederick, Daniel, Christoph, Martin, Christopher E., Mattner, Jochen, Seeberger, Peter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929054/ https://www.ncbi.nlm.nih.gov/pubmed/31692324 http://dx.doi.org/10.1021/acschembio.9b00642 |
Ejemplares similares
-
Protective Effects of Alginate and Chitosan Oligosaccharides against Clostridioides difficile Bacteria and Toxin
por: Mavrogeni, Maria Eleni, et al.
Publicado: (2023) -
Automated glycan assembly of Lewis type I and II oligosaccharide antigens
por: Guberman, Mónica, et al.
Publicado: (2019) -
Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model
por: Liu, Jinqiu, et al.
Publicado: (2023) -
Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021) -
Negative interactions determine Clostridioides difficile growth in synthetic human gut communities
por: Hromada, Susan, et al.
Publicado: (2021)